Protein Glutamine Gamma Glutamyltransferase 2 Market Size, Share, Analysis, Industry Report and Forecast 2021-2027

The global protein glutamine gamma glutamyltransferase 2 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). TG2 is a ubiquitous enzyme. It physiologically exerts multiple functions that are mostly linked to matrix assembly and tissue repair. The major factor accelerating the growth of the market is the rising incidence of celiac disease across the globe. According to Beyond Celiac, celiac disease damages the villi of the small intestine while interfering with the absorption of nutrients from food. Additionally, an estimated 1 in 133 Americans or about 1% of the population has celiac disease. Further, it is estimated that the prevalence of this disease is more than 1% in the US. Moreover, as per the mass screening program of children in Italy, the prevalence of celiac disease is estimated to be 1.6%. Apart from this, the prevalence of the celiac disease is estimated at 1.99% of the population in Finland. It can affect men and women of all ages and races. Hence, the increasing prevalence of this disease is driving the growth of the market.

To Request a Sample of our Report on Protein Glutamine Gamma Glutamyltransferase 2 Market: https://www.omrglobal.com/request-sample/protein-glutamine-gamma-glutamyltransferase-2-market

Some major players in the market include GlaxoSmithKline plc, Catabasis Pharmaceuticals Inc., and Zedira GmbH, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2019, Avalon Ventures announced entering into a definitive agreement with GlaxoSmithKline (GSK) to acquire Sitari Pharmaceuticals by GSK. The acquisition was aimed to give rights to GSK of a novel treatment being developed by Sitari for celiac disease.

Market Coverage

· The market number available for - 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- GlaxoSmithKline plc, Catabasis Pharmaceuticals Inc., and Zedira GmbH, among others.

(Get 15% Discount on Buying this Report)

A full Report of Protein Glutamine Gamma Glutamyltransferase 2 Market is Available @ https://www.omrglobal.com/industry-reports/protein-glutamine-gamma-glutamyltransferase-2-market

Global Protein Glutamine Gamma Glutamyltransferase 2 Market Report by Segment

By Type

• CAT-5571

• ERW-1041E

• ZED-1227

• Others

By Application

• Clinic

• Hospital

• Others

Global Protein Glutamine Gamma Glutamyltransferase 2 Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.